HJ03
HJ03 is a blood-brain barrier-permeable, orally active DNA damage and ferroptosis inducer. HJ03 triggers ferroptosis by increasing intracellular ROS, Fe2+ accumulation and lipid peroxidation. HJ03 induces DNA adducts and interstrand crosslinks, blocks DNA replication and transcription, arrests cells at the G2/M phase and induces apoptosis. HJ03 can be used in the research of glioblastoma multiforme and colorectal cancer.
For research use only. We do not sell to patients.
- CAS No.: 3028123-48-7
- Formula: C16H22Cl3N7O4
- Molecular Weight:482.75
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
All DNA/RNA Synthesis Isoforms
More
Biological Activity
Description
In Vitro
HJ03 (24-72 h) potently inhibits the viability of U251, U87, T98G, HCT116, MSH6-deficient U251 and MSH6-deficient T98G cells, with IC50 values ranging from 0.8914 μM to 61.65 μM after incubation for 24, 48, and 72 h. Its activity is independent of MGMT and MSH6 status[1].
HJ03 (0.25-8 μM; 14 days) inhibits colony formation of U251, U87 and T98G cells in a dose-dependent manner[1].
HJ03 (4-16 μM; 72 h) inhibits the viability of U87 spheroids and induces cell death, with 16 μM causing nearly complete spheroid death[1].
HJ03 (1-5 μM; 48-72 h) induces G2/M phase arrest in U251 and U87 cells, and regulates cell cycle-related proteins (p21, p-CDK1, CDK1, cyclin B1) in U251, U87 and T98G cells[1].
HJ03 (1-40 μM; 48-72 h) induces apoptosis in U251, U87 and T98G cells in a dose-dependent manner via cleavage of caspase-3/7/9 and PARP[1].
HJ03 (1-80 μM; 48-72 h) induces ferroptosis in U251, U87 and T98G cells through mechanisms involving upregulation of ROS, Fe2+ and MDA levels, downregulation of SLC7A11, as well as upregulation of p53 or ATF3[1].
HJ03 (0.4-50 μM; 15-72 h) induces DNA damage in U251, U87 and T98G cells through activating the ATM-Chk2 DNA damage response pathway; it also induces dose-dependent DNA cross-linking and alkylation in purified linearized pBR322 DNA[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only. Further protocols information, click here.
-
Cell Line:U251, U87, T98G
-
Concentration:0.25, 0.5 andn 1 μM (U251); 1, 2 and 4 μM (U87); 2, 4 and 8 μM (T98G)
-
Incubation Time:14 days
-
Result:Reduced colony formation significantly in U251 cells treated with 0.25, 0.5, or 1 μM compared to control.
Almost completely inhibited U87 cell colony formation at concentrations >2 μM.
Induced comparable colony formation inhibition in T98G cells treated with 2 μM to that of 50 μM TMZ.
-
Cell Line:U87
-
Concentration:4, 8 and 16 μM
-
Incubation Time:72 h
-
Result:Induced U87 spheroid shrinkage and cell death at 4 μM.
Caused almost complete spheroid death at 16 μM.
-
Cell Line:U251, U87, T98G
-
Concentration:1, 2 and 4 μM (U251); 5 μM (U87)
-
Incubation Time:48 h, 72 h
-
Result:Arrested 21.8%, 33%, and 70.3% of U251 cells in G2/M phase after 48 h treatment with 1, 2, 4 μM, respectively.
Increased G2/M arrest in U251 cells to 24.1%, 50.5%, and 67.8% after 72 h treatment with 1, 2, 4 μM, respectively.
Increased U87 cell G2/M arrest by >35% after 48 and 72 h treatment with 5 μM.
Increased p21 and p-CDK1, and decreased CDK1 and cyclin B1 in U251, U87, and T98G cells in a concentration-dependent manner.
-
Cell Line:U251, U87, T98G
-
Concentration:1, 2 and 4 μM (U251); 5, 10 and 20 μM (U87); 10, 20 and 40 μM (T98G)
-
Incubation Time:48 h, 72 h
-
Result:Induced significant apoptosis in U251 cells after 48 h incubation with 1, 2, 4 μM.
Triggered significant apoptosis in U87 cells after 48 h incubation with 5, 10, 20 μM.
Induced significant apoptosis in T98G cells after 48 h incubation with 20, 40 μM.
Parmacokinetics
| Species | Dose | Route | Cmax | Tmax (Plasma) | T1/2 | Tmax (Brain) |
|---|---|---|---|---|---|---|
| Mice[1] | 66 mg/kg | p.o. | 649.5 nM | 0.25 h | 0.4 h | 0.5 h |
In Vivo
HJ03 (2-132 mg/kg; p.o.; daily; 7 days) at doses up to 66 mg/kg is well-tolerated by healthy mice, with no significant weight loss or hematological toxicity, while the 132 mg/kg dose induces mild hematological toxicity[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:C57BL/6 (male, 8 weeks old, intracranial stereotactic injection of 2×105 firefly luciferase-expressing CT2A cells)[1]
-
Dosage:2 mg/kg; 20 mg/kg
-
Administration:p.o.; 5 consecutive days per week; 4 weeks
-
Result:Significantly prolonged mouse survival at 20 mg/kg compared to vehicle control and TMZ (HY-17364) groups.
Showed 20 mg/kg dose was significantly more effective than 2 mg/kg dose at prolonging survival.
Made treated mice regain lost body weight more quickly than TMZ-treated mice following treatment cessation.
-
Animal Model:C57BL/6 (male, 6-8 weeks old, 20±2 g)[1]
-
Dosage:2 mg/kg; 20 mg/kg; 66 mg/kg; 132 mg/kg
-
Administration:p.o.; daily; 7 days
-
Result:Caused no significant weight loss in any HJ03 dose group over 7-day treatment period.
Maintained white blood cell and lymphocyte counts within normal physiological ranges in 2, 20, and 66 mg/kg dose groups; induced significant decrease in white blood cell and lymphocyte counts below normal ranges only in 132 mg/kg dose group.
Kept red blood cell counts within normal ranges across all HJ03 dose groups.
Chemical Information
-
CAS No. 3028123-48-7
-
Molecular Weight 482.75
-
Formula C16H22Cl3N7O4
-
SMILES
ClCCNC(N(CCN(C1=CC=CC(Cl)=C1)CCN(C(NCCCl)=O)N=O)N=O)=O
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Protocols
-
Apoptosis
Apoptosis, also called programmed cell death, is generally characterized by distinct morphological characteristics.
-
TUNEL staining for apoptotic DNA fragmentation
TUNEL staining detects DNA strand breaks by using terminal deoxynucleotidyl transferase to add labeled nucleotides to exposed 3′-OH DNA termini, generating either microscopic staining in fixed cells or tissue sections, or fluorescence/cytometric signal in cell suspensions. TUNEL positivity reflects DNA fragmentation but should not be interpreted alone as definitive apoptosis, because TUNEL can also label necrotic, autolytic, mechanically damaged, or DNA-repair-associated DNA breaks.
-
PCNA Immunodetection Proliferation Assay
PCNA immunodetection measures proliferative activity by detecting proliferating cell nuclear antigen, a nuclear protein associated with DNA polymerase δ function and DNA replication. The assay readout is the proportion of PCNA-positive nuclei among total counted cells, but PCNA labeling is not identical to BrdU labeling because PCNA can mark late G1/early S-associated replication competence and may persist beyond active DNA synthesis depending on fixation and extraction conditions.
-
Flow cytometric DNA-content cell-cycle staining
Flow cytometric DNA-content cell-cycle staining measures the fluorescence intensity of DNA-bound fluorochromes in single cells or nuclei to estimate DNA content distributions, allowing assignment of populations to G0/G1, S, and G2/M phases by DNA histogram deconvolution. Propidium iodide (PI) intercalates into DNA, and PI fluorescence is proportional to cellular DNA content when staining is performed under conditions that make DNA accessible and minimize non-DNA signal. Cells with G2/M DNA content are expected to show approximately twice the fluorescence intensity of G0/G1 cells, while S-phase cells occupy intermediate fluorescence values. PI-based DNA-content analysis can also detect cells with fractional DNA content, often reported as sub-G1, when DNA fragmentation and extraction during staining reduce retained DNA signal in apoptotic cells. DAPI is an alternative DNA fluorochrome for univariate DNA-content analysis, while bivariate approaches combining DNA content with proliferation
-
Annexin V plus membrane-impermeant dye apoptosis staining
Annexin V-based apoptosis assays rely on the detection of phosphatidylserine (PS) externalization from the inner leaflet of the plasma membrane to the outer leaflet, an early biochemical hallmark of apoptosis. Fluorescently labeled Annexin V binds PS in a calcium-dependent manner, enabling identification of early apoptotic cells by flow cytometry or fluorescence microscopy. When combined with a membrane-impermeant DNA-binding dye (e. g. , propidium iodide), this approach allows discrimination between viable (Annexin V−/dye−), early apoptotic (Annexin V+/dye−), and late apoptotic or necrotic (Annexin V+/dye+) cell populations by assessing membrane integrity and PS exposure.
-
ROS/oxidative-stress fluorescent staining
ROS/oxidative-stress fluorescent staining uses cell-permeant fluorogenic probes that become fluorescent after oxidation inside cells or tissues; commonly used examples include DCFH-DA/DCFDA for broad cellular oxidant detection, DHE for superoxide-related signal detection, MitoSOX for mitochondrial superoxide-related signal detection, and CellROX probes for oxidative-stress-associated fluorescence readouts. The assay detects probe oxidation rather than a single ROS species unless the probe and analysis method have been chemically validated for that species. DCFH-DA enters cells, is deacetylated by intracellular esterases to DCFH, and produces fluorescent DCF after oxidation, so the readout is used as an operational measure of total cellular oxidative stress rather than a species-specific ROS measurement. DHE and MitoSOX can report superoxide-related oxidation, but red fluorescence alone can include non-specific ethidium-like oxidation products; HPLC or optimized spectral approaches are
-
Apoptosis Solutions
Apoptosis is a regulated, generally non-lytic cell-death pathway that removes unwanted, damaged, infected, or abnormal cells through coordinated morphological changes, caspase activation, DNA fragmentation, and membrane remodeling. The intrinsic apoptosis pathway is controlled mainly by mitochondrial outer membrane permeabilization, BCL-2 family proteins, cytochrome c release, apoptosome formation, caspase-9 activation, and downstream executioner caspase-3/7 activation. The extrinsic apoptosis pathway is initiated by death receptors such as Fas, TNFR, and TRAIL receptors, which recruit adaptor proteins and activate caspase-8 before engaging executioner caspases or mitochondrial amplification through BID cleavage. Apoptosis is linked to many phenotypes, including cancer cell killing, tissue homeostasis, immune regulation, neurodegeneration, infection response, and treatment-induced cytotoxicity; unresolved questions include how apoptosis interacts with necroptosis, pyroptosis, ferroptos
-
Protocol for Cell Cycle
Cell-cycle analysis by flow cytometry measures DNA content in single cells to estimate the fraction of cells in G0/G1, S, and G2/M phases. Propidium iodide intercalates into DNA, and after RNA removal with RNase, fluorescence intensity reflects cellular DNA content: 2N cells are assigned to G0/G1, cells between 2N and 4N to S phase, and 4N cells to G2/M. DNA-content analysis alone cannot reliably separate G0 from G1 or G2 from M. Ki-67 can distinguish quiescent G0 cells from cycling cells, EdU or BrdU incorporation marks active DNA synthesis in S phase, and phospho-histone H3 staining identifies mitotic cells within the 4N population.
-
Ferroptosis Solutions
Ferroptosis is an iron-dependent, non-apoptotic form of regulated cell death characterized by lethal lipid peroxidation and sensitivity to suppression by iron chelators or lipophilic radical-trapping antioxidants. The core pathway links cystine uptake through system Xc−, glutathione availability, GPX4-dependent detoxification of phospholipid hydroperoxides, iron-dependent oxidative reactions, and polyunsaturated-phospholipid metabolism into a cell-death program that is biochemically and morphologically distinct from apoptosis, necrosis, and autophagy. The ferroptosis pathway is experimentally linked to phenotype through chemical and genetic perturbation. Erastin induces ferroptosis by inhibiting cystine uptake through system Xc− and weakening antioxidant defenses, while GPX4 inhibition or depletion causes lipid peroxide accumulation and ferroptotic cancer-cell death. ACSL4 and oxidizable arachidonoyl- or adrenoyl-containing phosphatidylethanolamines shape ferroptosis sensitivity by con
-
Genotoxicity/Mutagenicity Study
The bacterial reverse mutation assay detects point mutations that restore amino-acid prototrophy in auxotrophic Salmonella typhimurium or Escherichia coli tester strains; after exposure to a test article, mutagenic activity is read out as an increased number of revertant colonies on minimal agar compared with the vehicle control. The assay uses tester strains with different mutation targets so that base-substitution and frameshift mutagens can be detected, and testing is performed with and without exogenous mammalian metabolic activation because some chemicals require biotransformation to become mutagenic.
Purity & Documentation
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)